Homburger advised HBM Healthcare Investments on the deal. HBM Healthcare Investments AG successfully issued CHF 100 m 1.125 per cent Bonds due 2027. The bonds will...
HBM Healthcare Investments’ CHF 100 Million Bonds Issuance
zvoove Group GmbH’s Acquisition of zvoove Switzerland AG
Homburger acted as counsel to DZ BANK AG Deutsche Zentral-Genossenschaftsbank. DZ BANK AG Deutsche Zentral-Genossenschaftsbank, Frankfurt am Main, acted as arranger, agent, security agent and lender...
UBS AG’s Green Bonds Offering
UBS AG, acting through its London branch, successfully completed its inaugural issuance of green bonds, consisting of (i) EUR 500 m 0.010 per cent. Notes due...
Platinum Equity’s Acquisition of Solenis
Homburger and Willkie Farr & Gallagher, Loyens & Loeff and SK&S advised Platinum Equity on the deal, while Debevoise & Plimpton LLP advised Clayton, Dubilier &...
Raiffeisen Schweiz’s CHF 300 Million AT1 Bonds Offering
Homburger advised Raiffeisen Schweiz Genossenschaft on the deal. Raiffeisen Schweiz Genossenschaft successfully issued AT1 Bonds in the total amount of CHF 300 m. (base tranche of CHF 200...
Molecular Partners’ $63.8 Million Initial Public Offering in The US and Listing on NASDAQ Close
Homburger advised Molecular Partners AG in the transaction, while Davis Polk and Advestra advised the joint book-running managers and representatives of the underwriters. Molecular Partners AG,...
UBS AG’s $3 Billion Senior Notes Issuance Under Its Euro Note Programme
Homburger advised UBS with respect to all transactional aspects of Swiss law. UBS AG, acting through its London branch, successfully completed its issuance of (i) USD...
UBS AG’s $3 Billion Senior Notes Issuance Under Its Euro Note Programme
Homburger advised UBS with respect to all transactional aspects of Swiss law. UBS AG, acting through its London branch, successfully completed its issuance of (i) USD...
Santhera Pharmaceuticals Holding AG’s First Exchange Offer For a Convertible Bond
Homburger acted as transaction counsel to Santhera in this matter. Santhera Pharmaceuticals Holding AG announced the settlement of the first exchange offer for a convertible bond...
PolyPeptide Group AG’s CHF 848 Million Initial Public Offering on SIX Swiss Exchange
Homburger acted as counsel to the underwriters, while Niederer Kraft Frey and Clifford Chance advised PolyPeptide Group. PolyPeptide Group AG, a global leader in peptide development and...
UBS AG’s €2.5 Billion Senior Notes Issuance Under Its Euro Note Programme
Homburger advised UBS AG on the deal. UBS AG, acting through its London branch, successfully completed its issuance of approximately EUR 2.5 bn in aggregate principal...
VectivBio’s Initial Public Offering And Listing on Nasdaq
Homburger advised VectivBio, while Latham & Watkins LLP and Niederer Kraft Frey represented the underwriters on the deal. VectivBio Holding AG announced its initial public offering...